Stereotaxis, Inc. (STXS)

USD 2.26

(-4.64%)

EBITDA Summary of Stereotaxis, Inc.

  • Stereotaxis, Inc.'s latest annual EBITDA in 2023 was -21.24 Million USD , down -13.14% from previous year.
  • Stereotaxis, Inc.'s latest quarterly EBITDA in 2024 Q1 was -4.6 Million USD , up 10.84% from previous quarter.
  • Stereotaxis, Inc. reported an annual EBITDA of -18.34 Million USD in 2022, down -24.58% from previous year.
  • Stereotaxis, Inc. reported an annual EBITDA of -12.78 Million USD in 2021, down -124.48% from previous year.
  • Stereotaxis, Inc. reported a quarterly EBITDA of -5.88 Million USD for 2024 Q2, down -27.77% from previous quarter.
  • Stereotaxis, Inc. reported a quarterly EBITDA of N/A for 2023 FY, down -13.14% from previous quarter.

Annual EBITDA Chart of Stereotaxis, Inc. (2023 - 2000)

Historical Annual EBITDA of Stereotaxis, Inc. (2023 - 2000)

Year EBITDA EBITDA Growth
2023 -21.24 Million USD -13.14%
2022 -18.34 Million USD -24.58%
2021 -12.78 Million USD -124.48%
2020 -6.58 Million USD -39.09%
2019 -4.7 Million USD -96.45%
2018 -1.78 Million USD 58.49%
2017 -5.08 Million USD 48.49%
2016 -5.85 Million USD -112.39%
2015 -4.34 Million USD -0.48%
2014 -4.67 Million USD 39.09%
2013 -7.62 Million USD 16.81%
2012 -9.02 Million USD 69.95%
2011 -26.75 Million USD -68.21%
2010 -14.96 Million USD 15.07%
2009 -20.69 Million USD 33.1%
2008 -38.45 Million USD 22.31%
2007 -45.88 Million USD -5.66%
2006 -45.06 Million USD -12.92%
2005 -41.88 Million USD -49.57%
2004 -26.68 Million USD -13.81%
2003 -23.44 Million USD -11.04%
2002 -21.11 Million USD -52.67%
2001 -13.83 Million USD -27.08%
2000 -10.88 Million USD 0.0%

Peer EBITDA Comparison of Stereotaxis, Inc.

Name EBITDA EBITDA Difference
InfuSystem Holdings, Inc. 16.59 Million USD 228.007%
Milestone Scientific Inc. -6.95 Million USD -205.418%
Retractable Technologies, Inc. -1.23 Million USD -1617.65%